Anti-RCAN2 monoclonal antibody

Pre-made anti-RCAN2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RCAN2/RCAN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1474-Ab-1/ GM-Tg-hg-IP1474-Ab-2Anti-Human RCAN2 monoclonal antibodyHuman
GM-Tg-rg-IP1474-Ab-1/ GM-Tg-rg-IP1474-Ab-2Anti-Rat RCAN2 monoclonal antibodyRat
GM-Tg-mg-IP1474-Ab-1/ GM-Tg-mg-IP1474-Ab-2Anti-Mouse RCAN2 monoclonal antibodyMouse
GM-Tg-cynog-IP1474-Ab-1/ GM-Tg-cynog-IP1474-Ab-2Anti-Cynomolgus/ Rhesus macaque RCAN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1474-Ab-1/ GM-Tg-felg-IP1474-Ab-2Anti-Feline RCAN2 monoclonal antibodyFeline
GM-Tg-cang-IP1474-Ab-1/ GM-Tg-cang-IP1474-Ab-2Anti-Canine RCAN2 monoclonal antibodyCanine
GM-Tg-bovg-IP1474-Ab-1/ GM-Tg-bovg-IP1474-Ab-2Anti-Bovine RCAN2 monoclonal antibodyBovine
GM-Tg-equg-IP1474-Ab-1/ GM-Tg-equg-IP1474-Ab-2Anti-Equine RCAN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1474-Ab-1/ GM-Tg-hg-IP1474-Ab-2; GM-Tg-rg-IP1474-Ab-1/ GM-Tg-rg-IP1474-Ab-2;
GM-Tg-mg-IP1474-Ab-1/ GM-Tg-mg-IP1474-Ab-2; GM-Tg-cynog-IP1474-Ab-1/ GM-Tg-cynog-IP1474-Ab-2;
GM-Tg-felg-IP1474-Ab-1/ GM-Tg-felg-IP1474-Ab-2; GM-Tg-cang-IP1474-Ab-1/ GM-Tg-cang-IP1474-Ab-2;
GM-Tg-bovg-IP1474-Ab-1/ GM-Tg-bovg-IP1474-Ab-2; GM-Tg-equg-IP1474-Ab-1/ GM-Tg-equg-IP1474-Ab-2
Products NameAnti-RCAN2 monoclonal antibody
Formatmab
Target NameRCAN2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RCAN2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1474-Ag-1Recombinant multi-species RCAN2/ CSP2/ DSCR1L1 protein


    Target information

    Target IDGM-IP1474
    Target NameRCAN2
    Gene ID10231,53901,140666,704128,609864,101099716,525636,100055752
    Gene Symbol and SynonymsCSP2,Dcip2,DSCR1L1,MCIP2,RCAN2,RCN2,ZAKI-4,ZAKI4
    Uniprot AccessionQ14206,Q8CH27,Q3ZC15
    Uniprot Entry NameRCAN2_HUMAN,RCAN2_RAT,RCAN2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172348
    Target ClassificationN/A

    The target: RCAN2, gene name: RCAN2, also named as CSP2, DSCR1L1, MCIP2, RCN2, ZAKI-4, ZAKI4. This gene encodes a member of the regulator of calcineurin (RCAN) protein family. These proteins play a role in many physiological processes by binding to the catalytic domain of calcineurin A, inhibiting calcineurin-mediated nuclear translocation of the transcription factor NFATC1. Expression of this gene in skin fibroblasts is upregulated by thyroid hormone, and the encoded protein may also play a role in endothelial cell function and angiogenesis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.